| Lignocaine (Lidocaine) Intravenous And Endotracheal (Cardiac) |
| SCOPE (Area): Emergency, Operating Suite, ICU, (Exclude: Paediatrics Seek Advice), (Exclude: General Wards), Cardiovascular Suite, Coronory Care Unit |
| SCOPE (Staff): Medical, Nursing, Pharmacy |
Printed versions of this document SHOULD NOT be considered up to date / current
Exclusions
| Paediatrics (seek Paediatrician advice) and General Wards |
Preamble
See Appendix for full version of this Drug Guideline. |
Related Documents
References
 |
Barwon Health (2019, February). Lidocaine (Lignocaine) for cardiac arrhythmias. Barwon Health. Personal communication received March 2019. |
 |
CRC Press Taylor & Francis Group. (2019). Renal Drug Database. Retrieved April 12, 2019 from |
|
IBM Corporation. (2019). IBM Micromedex. Retrieved April 12, 2019, from |
|
MIMS Online. (2019, April). MIMS Online, Min-I-jet Lignocaine Hydrochloride Injection product information. Retrieved April 12, 2019, from |
|
MIMS Online. (2019, April). MIMS Online, Xylocaine® product information. Retrieved April 12, 2019, from |
|
MIMS Online. (2019, April). MIMS Online, Xylocard® product information. Retrieved April 12, 2019, from |
|
Rossi, S. (2019, January). Australian Medicines Handbook. Retrieved April 12, 2019, from |
|
The Society of Hospital Pharmacists of Australia. (2019, February). Australian Injectable Drugs Handbook (7th ed.). Retrieved April 12, 2019, from |
|
Therapeutic Guidelines Limited. (2018, March). Cardiovascular Guidelines. Retrieved April 12, 2019 from |
|
Wolters Kluwer. (2019). UpToDate. Retrieved August 12, 2019, from |
Appendix
| Reg Authority: Medication Safety & Governance Committee (MSGC) |
Date Effective: 30/09/2020 |
| Review Responsibility: Pharmacist - Rotational |
Date for Review: 30/09/2024 |
Lignocaine (Lidocaine) Intravenous And Endotracheal (Cardiac) - DRG0028 - Version: 6 - (Generated On: 03-07-2025 05:46) |
